ANTICOAGULANT DOSING CONVERSIONS; Conversion of DABIGATRAN ETEXILATE: Switching from DABIGATRAN to WARFARIN • Adjust starting time of warfarin based on CrCl as follows: ...

If you've been diagnosed with a deep venous thrombosis (DVT), you can expect at least three months of continued anticoagulants, or blood-thinning medications, such as warfarin, after you leave the ...

Findings from a recent study suggests that clinical and genetic factors affecting warfarin dose requirements differ by race. The study is published in the journal Blood.Blood.

Incorporating genetic information into clinical algorithms may help clinicians better determine optimal doses of warfarin for patients who require doses higher and lower than the mean, according ...

Patients using warfarin for oral anticoagulant therapy need to be frequently monitored because of warfarin's narrow therapeutic range and the large variation in dose requirements among patients ...

Among 1,650 randomized patients, 97 percent received at least 1 dose of warfarin therapy and completed the trial (n = 808 in genotype-guided group vs n = 789 in clinically-guided group).

Trial will test informatics software used in Warfarin dosing. Louisville-based PGXL Laboratories has received an OK from regulators to conduct clinical trials on its informatics software, called ...

Dosing Crucial for Digoxin, Warfarin Safety — Digoxin unsafe at high levels regardless of heart failure by Nicole Lou , Staff Writer, MedPage Today March 21, 2017 • 3 min read ...

In the first genome-wide association study to focus on warfarin dose requirement in African-Americans, a multi-institutional team of researchers has identified a common genetic variation that can ...

Nevertheless, warfarin has a delayed onset of action, requires monitoring of coagulation and dose adjustment, and has multiple interactions with food and drugs. 33,34 The results of our study ...

Pharmacogenetic-guided dosing of warfarin and other coumarin derivatives seems to be a promising new method to improve the safety and efficacy of oral anticoagulant therapy. Currently, the ...